The West Yorkshire Low Intensity Outcome Watch (WYLOW) was a prospective, longitudinal cohort study. The study recruited 439 patients with depression and anxiety disorders who completed LiCBT interventions in a stepped care psychological therapy service linked to the Improving Access to Psychological Therapies (IAPT) programme in England. LiCBT interventions were highly standardised, were delivered by trained psychological wellbeing practitioners, and included individual, group, and online forms of treatment delivery, consistent with clinical guidelines [9] . Participants were eligible for inclusion if they completed LiCBT with remission of depression and anxiety symptoms, which were established using diagnostic cut-offs on the PHQ-9 [10] and GAD-7 [11] measures. Participants were contacted once per month by the research team, and completed these measures to monitor their symptoms for up to 24 months. Cases that met the criteria for reliable (increase >5 points) and clinically significant (above diagnostic cut-off) deterioration of symptoms on any of the 2 measures during follow-up were classified as having a risk event. Consistent with previous research [1-3], a risk event was considered a relapse if it occurred within 12 months after treatment, and a recurrence if it occurred after 12 months. We performed a survival analysis using Kaplan-Meier (KM) curves to model "time to event" in months. KM curves plot the probability of survival (remission) over time, while taking account of censored (i.e., missing) data points.
Depression and anxiety disorders are highly prevalent and relapse-prone conditions [1, 2] . Cognitive behavioural therapy (CBT), a well-established psychological intervention, has been shown to reduce the longer-term risk of depression relapse. For example, average relapse rates following CBT (∼30%) compare favourably to relapse rates observed after discontinued pharmacotherapy, which tend to be upwards of 50% [3, 4] . In spite of the effectiveness and durability of CBT for common mental health problems, barriers to its dissemination include the cost of delivery and the scarce availability of specialists in many countries. In order to overcome such barriers, briefer and less costly "low intensity" forms of CBT (LiCBT) have been developed to guide people on how they could self-manage and overcome their symptoms [5] . LiCBT can be delivered by trained coaches or lay helpers, using a variety of methods including individual, group-based, telephonebased, or online support. Meta-analyses of controlled trials support the use of LiCBT for the treatment of acute depression and anxiety symptoms, although there is still inconclusive evidence about its longer-term effects [6, 7] . Given its short-term duration (typically <8 sessions), LiCBT does not usually allow for intensive relapse prevention work or booster sessions that may account for the durability of more intensive CBT interventions [8] . For this reason, prospective follow-up studies are necessary to establish whether the effects of LiCBT are as durable as those observed in more conventional CBT interventions. This study reports relapse and recurrence rates in a cohort of patients who completed LiCBT in routine care, and who were followed up on a monthly basis for up to 2 years after treatment. 117 critical period where the majority (2 out of 3) of relapse-prone cases become apparent. Consistent with earlier studies, we have previously reported that patients who completed therapy with residual depression symptoms (PHQ-9 = 5-9) had double the risk of relapse within the first year [12] .
Some limitations in this study concern cases lost to follow-up, and the lack of structured diagnostic interviews to establish whether participants met full diagnostic criteria for a mental disorder during the follow-up phase. To deal with the first challenge, we applied "censoring" in survival analysis, which is appropriate to deal with missing data. Regarding the second problem, we applied a stringent and conservative operational definition of relapse, based on the observation of both statistically reliable and clinically important deterioration in well-established depression and anxiety measures [10, 11] .
On balance, the present results indicate that LiCBT can be an effective way to treat the acute symptoms of depression and anxiety disorders, although dedicating time and attention to relapse prevention strategies [3, 8] is a clear area for future development. The findings support the notion that, for some individuals, problems like depression are experienced as long-term and recurrent conditions and therefore self-management support should be an important component of psychological care.
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